From immunohistochemistry to spatial omics: A new era of tissue-based research in pathology
Modern pathology increasingly links tissue-based diagnostics with therapeutic decision-making. Spatial multiomics enables high-resolution interrogation of tumour biology in its native tissue context and can reveal actionable therapeutic targets and spatially defined patient subgroups. Spatially restricted histomorphological features such as tumour budding or direct tumour-adipocyte contact/Stroma AReactive Invasion Front Areas (TAC/SARIFA) illustrate that tissue architecture itself encodes biological information. Spatial omics can dissect the cellular and molecular programmes underlying such patterns, but high costs and analytical complexity require careful study design and pathology-guided tissue selection. Combined with scalable approaches such as immunohistochemistry and computational pathology, spatial profiling can support biomarker discovery, biological interpretation, and clinical translation.
Authors
- Steffen Ormanns (ORCID: https://orcid.org/0000-0002-0754-9034)
- Nic Gabriel Reitsam (ORCID: https://orcid.org/0000-0002-0070-3158)
- Michael Günther
Institutions
- Innsbruck Medical University (AT)
- University of Augsburg (DE)
- Universität Innsbruck (AT)
Publication Details
- Journal
- Die Pathologie
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s00292-026-01614-2
- Primary Topic
- Single-cell and spatial transcriptomics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Medizinische Universität Innsbruck
- Universität Innsbruck